Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EDITEditas Medicine, Inc.

Nasdaq · CIK 0001650664
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts323

Identity from submissions API

NameEditas Medicine, Inc.
CIK0001650664
TickersEDIT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN464097528
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-401-9000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
11 HURLEY ST.
CAMBRIDGE
MA
02141
MA
Mailing address
11 HURLEY ST.
CAMBRIDGE
MA
02141
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

733 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 4 FORM 4 0001650664-26-000105 5506
2026-11-13 4 FORM 4 0001650664-26-000104 5484
2026-11-09 10-Q 10-Q 0001650664-26-000103 001-37687 261536011 34 7854115 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001650664-26-000100 001-37687 261533770 34 326537 1 1
2026-11-06 4 FORM 4 0001985604-26-000005 4845
2026-11-06 4 FORM 4 0001742084-26-000005 4864
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003773 005-89319 261491620 34 10838
2026-10-08 8-K 8-K 7.01,8.01,9.01 0001650664-26-000093 001-37687 261448289 34 292599 1 1
2026-09-09 4 FORM 4 0002149618-26-000006 5563
2026-09-09 3 FORM 3 0002149618-26-000005 11562
2026-09-09 S-8 S-8 0001650664-26-000090 333-298828 261368404 33 218529 1 1
2026-09-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002915 333-298665 261366521 33 1713
2026-09-04 4 FORM 4 0001985604-26-000003 5593
2026-09-04 4 FORM 4 0002063082-26-000006 5017
2026-09-04 4 FORM 4 0001742084-26-000003 5615
2026-08-31 S-3 S-3 0001104659-26-103906 333-298665 261346875 33 2105636 1 1
2026-08-31 144 xsl144X01/primary_doc.xml 0001650664-26-000087 001-37687 261346578 33 4874
2026-08-31 144 xsl144X01/primary_doc.xml 0001650664-26-000085 001-37687 261346550 33 5375
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097420 005-89319 261284491 34 14716
2026-08-07 4 FORM 4 0002137699-26-000004 5420
2026-08-07 3 FORM 3 0002137699-26-000003 446678
2026-08-05 4 FORM 4 0002063082-26-000003 5013
2026-08-05 10-Q 10-Q 0001650664-26-000083 001-37687 261243354 34 6276831 1 1
2026-08-05 8-K 8-K 2.02,5.02,9.01 0001650664-26-000082 001-37687 261243261 34 323398 1 1
2026-07-29 4 FORM 4 0001650664-26-000076 5119
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002798 005-89319 261216845 34 10887
2026-07-21 144 xsl144X01/primary_doc.xml 0001650664-26-000074 001-37687 261190665 33 4789
2026-06-22 4 FORM 4 0001650664-26-000072 5428
2026-06-22 4 FORM 4 0001650664-26-000071 5393
2026-06-22 4 FORM 4 0001650664-26-000070 5391
2026-06-22 4 FORM 4 0001650664-26-000069 5353
2026-06-22 4 FORM 4 0001650664-26-000068 5396
2026-06-18 8-K 8-K 5.07 0001650664-26-000063 001-37687 261103146 34 159544 1 1
2026-06-05 4 FORM 4 0001650664-26-000057 5480
2026-06-05 4 FORM 4 0001650664-26-000056 5611
2026-06-05 4 FORM 4 0001650664-26-000055 5589
2026-06-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000168 005-89319 261061573 34 18746
2026-06-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-255480 005-89319 261060854 34 124416
2026-06-02 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000027 005-89319 261057947 34 15612
2026-05-29 144 xsl144X01/primary_doc.xml 0001650664-26-000052 001-37687 261045420 33 4872
2026-05-26 424B5 424B5 0001104659-26-066382 333-277471 261021279 33 723830
2026-05-26 8-K FORM 8-K 1.01,8.01,9.01 0001104659-26-066317 001-37687 261020594 34 739833 1 1
2026-05-26 S-3MEF S-3MEF 0001104659-26-066034 333-296213 261016043 33 225679 1 1
2026-05-26 8-K FORM 8-K 8.01 0001104659-26-066021 001-37687 261015998 34 187514 1 1
2026-05-26 424B5 424B5 0001104659-26-065944 333-277471 261015856 33 737858
2026-05-26 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-065908 001-37687 261015823 34 227023 1 1
2026-05-14 8-K 8-K 7.01,8.01,9.01 0001650664-26-000049 001-37687 26975704 34 204913 1 1
2026-05-05 10-Q 10-Q 0001650664-26-000045 001-37687 26943442 34 5074561 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001650664-26-000043 001-37687 26940381 34 312191 1 1
2026-04-28 ARS ARS 0001650664-26-000039 001-37687 26908566 34 62066065
2026-04-28 DEFA14A DEFA14A 0001650664-26-000038 001-37687 26908523 34 490355
2026-04-28 DEF 14A DEF 14A 0001650664-26-000037 001-37687 26908486 34 7935332 1 1
2026-04-07 8-K 8-K 4.01,9.01 0001650664-26-000030 001-37687 26845288 34 161641 1 1
2026-03-27 8-K 8-K 7.01,8.01,9.01 0001650664-26-000027 001-37687 26801015 34 181138 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001154 005-89319 26799916 34 7072
2026-03-16 4 FORM 4 0001650664-26-000023 5312
2026-03-16 4 FORM 4 0001650664-26-000022 5293
2026-03-16 4 FORM 4 0001650664-26-000021 5291
2026-03-09 10-K 10-K 0001650664-26-000017 001-37687 26735820 34 11935167 1 1
2026-03-09 8-K 8-K 2.02,9.01 0001650664-26-000013 001-37687 26733151 34 325361 1 1
2026-03-04 4 FORM 4 0001650664-26-000009 5472
2026-03-04 4 FORM 4 0001650664-26-000007 5342
2026-03-04 4 FORM 4 0001650664-26-000006 5450
2026-02-27 144 xsl144X01/primary_doc.xml 0001650664-26-000002 001-37687 26700729 33 4880
2025-12-04 4 FORM 4 0001650664-25-000163 4986
2025-12-04 4 FORM 4 0001650664-25-000162 5008
2025-12-04 4 FORM 4 0001650664-25-000161 4879
2025-12-01 144 xsl144X01/primary_doc.xml 0001650664-25-000158 001-37687 251540561 33 4882
2025-11-10 10-Q 10-Q 0001650664-25-000156 001-37687 251466136 34 5768415 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001650664-25-000153 001-37687 251464291 34 318957 1 1
2025-10-09 8-K 8-K 7.01,8.01,9.01 0001650664-25-000148 001-37687 251385443 34 191230 1 1
2025-09-04 4 FORM 4 0001650664-25-000143 5225
2025-09-04 4 FORM 4 0001650664-25-000142 4880
2025-09-04 4 FORM 4 0001650664-25-000141 5009
2025-09-02 8-K 8-K 7.01,8.01,9.01 0001650664-25-000134 001-37687 251282921 34 207380 1 1
2025-08-29 144 xsl144X01/primary_doc.xml 0001650664-25-000130 001-37687 251281449 33 4883
2025-08-29 144 xsl144X01/primary_doc.xml 0001650664-25-000128 001-37687 251281228 33 5397
2025-08-12 10-Q 10-Q 0001650664-25-000125 001-37687 251206724 34 9663978 1 1
2025-08-12 8-K 8-K 2.02,9.01 0001650664-25-000123 001-37687 251206545 34 312966 1 1
2025-08-08 4 FORM 4 0001650664-25-000118 4873
2025-08-04 4 FORM 4 0001650664-25-000113 4984
2025-07-30 144 xsl144X01/primary_doc.xml 0001650664-25-000110 001-37687 251167252 33 4811
2025-06-12 8-K 8-K 7.01,8.01,9.01 0001650664-25-000106 001-37687 251041614 34 193931 1 1
2025-06-10 4 FORM 4 0001650664-25-000103 13778
2025-06-10 4 FORM 4 0001650664-25-000102 13954
2025-06-10 4 FORM 4 0001650664-25-000101 13691
2025-06-10 4 FORM 4 0001650664-25-000100 13675
2025-06-10 4 FORM 4 0001650664-25-000099 13627
2025-06-04 4 FORM 4 0001650664-25-000093 5342
2025-06-04 4 FORM 4 0001650664-25-000091 5451
2025-06-04 4 FORM 4 0001650664-25-000089 14088
2025-06-02 144 xsl144X01/primary_doc.xml 0001650664-25-000087 001-37687 251016275 33 4895
2025-06-02 8-K 8-K 5.02,5.03,5.07,9.01 0001650664-25-000086 001-37687 251016236 34 340003 1 1
2025-05-14 8-K 8-K 7.01,8.01,9.01 0001650664-25-000081 001-37687 25942603 34 211388 1 1
2025-05-13 8-K 8-K 7.01,8.01,9.01 0001650664-25-000077 001-37687 25937092 34 210894 1 1
2025-05-12 10-Q 10-Q 0001650664-25-000073 001-37687 25935900 34 5328826 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001650664-25-000071 001-37687 25935392 34 330031 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000589 005-89319 25844526 34 10794
2025-04-15 ARS ARS 0001650664-25-000064 001-37687 25840066 34 23955527
2025-04-15 DEFA14A DEFA14A 0001650664-25-000060 001-37687 25839711 34 414504
2025-04-15 DEF 14A DEF 14A 0001650664-25-000058 001-37687 25839694 34 8015097 1 1
2025-04-08 4 FORM 4 0001650664-25-000052 5383
2025-04-08 3 FORM 3 0001650664-25-000050 453181
2025-04-04 PRE 14A PRE 14A 0001650664-25-000045 001-37687 25815453 34 7996161 1 1
2025-03-27 4 FORM 4 0001650664-25-000040 7436
2025-03-27 4 FORM 4 0001650664-25-000037 7451
2025-03-27 4 FORM 4 0001650664-25-000034 7430
2025-03-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000727 333-277471 25762105 33 1725
2025-03-20 8-K 8-K 5.02 0001650664-25-000031 001-37687 25756928 34 150251 1 1
2025-03-05 POS AM POS AM 0001104659-25-020955 333-277471 25712336 33 622784
2025-03-05 4 FORM 4 0001650664-25-000027 448576
2025-03-05 4 FORM 4 0001650664-25-000026 449309
2025-03-05 4 FORM 4 0001650664-25-000025 448996
2025-03-05 S-8 S-8 0001650664-25-000024 333-285576 25711876 33 175220
2025-03-05 10-K 10-K 0001650664-25-000022 001-37687 25711427 34 31919737 1 1
2025-03-05 8-K 8-K 2.02,9.01 0001650664-25-000020 001-37687 25711077 34 340041 1 1
2025-03-05 POSASR POSASR 0001104659-25-020876 333-277471 25710939 33 980466
2025-02-28 144 xsl144X01/primary_doc.xml 0001650664-25-000009 001-37687 25691176 33 4900
2025-02-28 144 xsl144X01/primary_doc.xml 0001650664-25-000007 001-37687 25691133 33 4218
2025-02-28 144 xsl144X01/primary_doc.xml 0001650664-25-000005 001-37687 25691047 33 4231
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000880 005-89319 25623545 34 11224
2025-01-13 8-K 8-K 2.02,7.01,9.01 0001650664-25-000003 001-37687 25525055 34 214620 1 1
2024-12-17 8-K 8-K 5.02 0001650664-24-000144 001-37687 241555879 34 148853 1 1
2024-12-12 8-K 8-K 2.05,5.02,7.01,8.01,9.01 0001650664-24-000141 001-37687 241544860 34 213081 1 1
2024-12-10 8-K 8-K 5.03,7.01,9.01 0001650664-24-000138 001-37687 241536740 34 8598524 1 1
2024-12-05 4 FORM 4 0001650664-24-000126 5485
2024-12-05 4 FORM 4 0001650664-24-000124 5520
2024-11-12 SC 13G/A UnitedStates_13G__EditasMedi.txt 0000932471-24-000974 005-89319 241446995 34 6502
2024-11-04 SC 13G/A UnitedStates_13G__EditasMedi.txt 0000932471-24-000483 005-89319 241421767 34 5574
2024-11-04 10-Q 10-Q 0001650664-24-000121 001-37687 241420768 34 4551010 1 1
2024-11-04 8-K 8-K 2.02,9.01 0001650664-24-000120 001-37687 241420762 34 336070 1 1
2024-10-22 8-K 8-K 2.02,7.01,9.01 0001650664-24-000114 001-37687 241384658 34 208994 1 1
2024-10-17 SC 13G/A Editas_Medicine_Inc.htm 0000093751-24-000835 005-89319 241376858 34 55943
2024-10-04 8-K 8-K 1.01,2.03,7.01,9.01 0001650664-24-000111 001-37687 241352897 34 195357 1 1
2024-09-06 4 FORM 4 0001650664-24-000105 5520
2024-09-06 4 FORM 4 0001650664-24-000103 5485
2024-08-29 144 xsl144X01/primary_doc.xml 0001650664-24-000100 001-37687 241264005 33 4901
2024-08-29 144 xsl144X01/primary_doc.xml 0001650664-24-000099 001-37687 241263956 33 5425
2024-08-07 10-Q 10-Q 0001650664-24-000097 001-37687 241183853 34 4375571 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001650664-24-000094 001-37687 241181390 34 308525 1 1
2024-07-26 4 FORM 4 0001650664-24-000090 4992
2024-07-22 4 FORM 4 0001650664-24-000087 5517
2024-07-18 144 xsl144X01/primary_doc.xml 0001650664-24-000084 001-37687 241125762 33 4844
2024-07-18 144 xsl144X01/primary_doc.xml 0001650664-24-000082 001-37687 241124958 33 4234
2024-07-10 SC 13G/A Editas_Medicine_Inc.txt 0000093751-24-000653 005-89319 241108639 34 8465
2024-06-27 8-K 8-K 5.02 0001650664-24-000081 001-37687 241080180 34 146283 1 1
2024-06-14 8-K 8-K 7.01,8.01,9.01 0001650664-24-000078 001-37687 241043009 34 250903 1 1
2024-06-06 4 FORM 4 0001650664-24-000076 5012
2024-06-06 4 FORM 4 0001650664-24-000075 5047
2024-06-03 4 FORM 4 0001650664-24-000072 5220
2024-06-03 4 FORM 4 0001650664-24-000071 5267
2024-06-03 4 FORM 4 0001650664-24-000070 5265
2024-06-03 4 FORM 4 0001650664-24-000068 5259
2024-06-03 4 FORM 4 0001650664-24-000060 5259
2024-06-03 4 FORM 4 0001650664-24-000058 5265
2024-06-03 4 FORM 4 0001650664-24-000056 5289
2024-06-03 4 FORM 4 0001650664-24-000054 5228
2024-05-31 144 xsl144X01/primary_doc.xml 0001650664-24-000052 001-37687 241010057 33 4904
2024-05-31 144 xsl144X01/primary_doc.xml 0001650664-24-000051 001-37687 241010036 33 4833
2024-05-31 8-K 8-K 5.07 0001650664-24-000050 001-37687 241009912 34 168279 1 1
2024-05-22 4 FORM 4 0001650664-24-000044 4997
2024-05-17 144 xsl144X01/primary_doc.xml 0001650664-24-000041 001-37687 24960362 33 4221
2024-05-14 4 FORM 4 0001650664-24-000039 4957
2024-05-08 10-Q 10-Q 0001650664-24-000037 001-37687 24926528 34 4099702 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001650664-24-000034 001-37687 24924219 34 310570 1 1
2024-04-16 DEFA14A DEFA14A 0001650664-24-000028 001-37687 24848169 34 376062
2024-04-16 DEF 14A DEF 14A 0001650664-24-000025 001-37687 24848127 34 8590105 1 1
2024-04-10 SC 13G/A Editas_Medicine_Inc.txt 0000093751-24-000574 005-89319 24834393 34 10340
2024-03-05 4 FORM 4 0001650664-24-000019 9132
2024-03-05 4 FORM 4 0001650664-24-000017 9122
2024-03-05 4 FORM 4 0001650664-24-000015 13085
2024-03-05 4 FORM 4 0001650664-24-000013 13124
2024-03-04 144 xsl144X01/primary_doc.xml 0001650664-24-000011 001-37687 24716852 33 4301
2024-02-28 S-3ASR S-3ASR 0001628280-24-007660 333-277471 24696835 33 2236339
2024-02-28 S-8 S-8 0001628280-24-007619 333-277459 24696201 33 158979
2024-02-28 10-K 10-K 0001650664-24-000008 001-37687 24695496 34 9578415 1 1
2024-02-28 8-K 8-K 2.02,9.01 0001650664-24-000006 001-37687 24690140 34 238135 1 1
2024-02-14 SC 13G/A deeptrack-edit123123a1.htm 0001172661-24-000916 005-89319 24632631 34 103002
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020817 005-89319 24628446 34 12994
2024-01-24 SC 13G/A us28106w1036_012424.txt 0001086364-24-002241 005-89319 24555797 34 13581
2024-01-10 SC 13G/A Editas_Medicine_Inc.txt 0000093751-24-000017 005-89319 24525045 34 8457
2023-12-13 8-K 8-K 7.01,8.01,9.01 0001650664-23-000038 001-37687 231483073 34 698086 1 1
2023-12-11 8-K 8-K 7.01,8.01,9.01 0001650664-23-000034 001-37687 231478449 34 1500984 1 1
2023-12-07 4 FORM 4 0001650664-23-000029 5429
2023-11-22 8-K 8-K 5.02,9.01 0001650664-23-000026 001-37687 231433519 34 269789 1 1
2023-11-16 4 FORM 4 0001650664-23-000022 4958
2023-11-09 4 FORM 4 0001650664-23-000019 4955
2023-11-03 10-Q 10-Q 0001650664-23-000017 001-37687 231376254 34 8334821 1 1
2023-11-03 8-K 8-K 2.02,9.01 0001650664-23-000014 001-37687 231374471 34 237458 1 1
2023-10-10 8-K 8-K 5.02 0001650664-23-000005 001-37687 231317966 34 153362 1 1
2023-09-07 4 FORM 4 0001650664-23-000002 4956
2023-08-15 4 xslF345X05/form4-08152023_040803.xml 0001415889-23-012264 4874
2023-08-10 4 xslF345X05/form4-08102023_040848.xml 0001415889-23-012049 4871
2023-08-04 SC 13G deeptrack-edit072623.htm 0001172661-23-002763 005-89319 231144253 34 102877
2023-08-02 10-Q 10-Q 0001558370-23-012936 001-37687 231136194 34 5844088 1 1
2023-08-02 8-K 8-K 2.02,9.01 0001558370-23-012810 001-37687 231133716 34 262234 1 1
2023-07-25 4 xslF345X05/form4-07252023_040701.xml 0001415889-23-011455 7236
2023-07-25 3 xslF345X02/form3-07252023_080727.xml 0001415889-23-011454 12541
2023-07-21 4 xslF345X05/form4-07212023_040701.xml 0001415889-23-011382 4880
2023-06-15 8-K 8-K 1.01,8.01,9.01 0001558370-23-011141 001-37687 231017808 34 489446 1 1
2023-06-15 424B5 424B5 0001104659-23-071618 333-253715 231017646 33 858682
2023-06-14 424B5 424B5 0001104659-23-071267 333-253715 231015120 33 823890
2023-06-09 8-K 8-K 7.01,8.01,9.01 0001558370-23-010931 001-37687 231003776 34 291891 1 1
2023-06-07 4 xslF345X04/form4-06072023_040605.xml 0001415889-23-009369 5314
2023-06-07 4 xslF345X04/form4-06072023_040602.xml 0001415889-23-009368 5339
2023-06-05 4 xslF345X04/form4-06052023_040609.xml 0001415889-23-009232 5198
2023-06-05 4 xslF345X04/form4-06052023_040621.xml 0001415889-23-009236 5232
2023-06-05 4 xslF345X04/form4-06052023_040625.xml 0001415889-23-009237 5202
2023-06-05 4 xslF345X04/form4-06052023_040619.xml 0001415889-23-009234 5170
2023-06-05 4 xslF345X04/form4-06052023_040604.xml 0001415889-23-009231 5202
2023-06-05 4 xslF345X04/form4-06052023_040614.xml 0001415889-23-009233 5164
2023-06-05 4 xslF345X04/form4-06052023_040602.xml 0001415889-23-009230 5208
2023-06-05 8-K 8-K 5.07 0001558370-23-010811 001-37687 23992640 34 166140 1 1
2023-06-02 144 xsl144X01/primary_doc.xml 0001415889-23-009115 001-37687 23989573 33 4535
2023-05-18 4 xslF345X04/form4-05182023_090554.xml 0001415889-23-008293 7236
2023-05-18 3 xslF345X02/form3-05182023_090528.xml 0001415889-23-008291 12530
2023-05-17 8-K 8-K 5.02 0001558370-23-010139 001-37687 23932166 34 152789 1 1
2023-05-15 4 xslF345X04/form4-05152023_040503.xml 0001415889-23-007990 4920
2023-05-15 4 xslF345X04/form4-05152023_040501.xml 0001415889-23-007989 4870
2023-05-11 144 xsl144X01/primary_doc.xml 0001415889-23-007832 001-37687 23912651 33 5808
2023-05-11 4 xslF345X04/form4-05112023_040501.xml 0001415889-23-007816 5359
2023-05-05 10-Q 10-Q 0001558370-23-008308 001-37687 23894051 34 4917318 1 1
2023-05-05 8-K 8-K 2.02,9.01 0001558370-23-008190 001-37687 23891219 34 324668 1 1
2023-04-18 ARS ARS 0001104659-23-046740 001-37687 23827255 34 5039491
2023-04-18 DEFA14A DEFA14A 0001104659-23-046738 001-37687 23827235 34 374618
2023-04-18 DEF 14A FORM DEF 14A 0001104659-23-046732 001-37687 23827194 34 10681511 1 1
2023-04-13 8-K 8-K 5.02 0001558370-23-005886 001-37687 23819081 34 151389 1 1
2023-04-13 4 xslF345X04/form4-04132023_080436.xml 0001415889-23-006521 5309
2023-04-13 3 xslF345X02/form3-04132023_080428.xml 0001415889-23-006520 12714
2023-03-14 8-K 8-K 5.02,5.03,9.01 0001558370-23-003731 001-37687 23731664 34 379845 1 1
2023-03-06 4 xslF345X03/form4-03062023_040309.xml 0001415889-23-004315 9129
2023-03-06 4 xslF345X03/form4-03062023_040307.xml 0001415889-23-004314 7184
2023-03-06 4 xslF345X03/form4-03062023_040304.xml 0001415889-23-004313 7168
2023-03-06 4 xslF345X03/form4-03062023_040302.xml 0001415889-23-004312 9078
2023-02-22 S-8 S-8 0001558370-23-001769 333-269917 23653934 33 179931
2023-02-22 10-K 10-K 0001558370-23-001764 001-37687 23653636 34 10278275 1 1
2023-02-22 8-K 8-K 2.02,9.01 0001558370-23-001684 001-37687 23650472 34 384741 1 1
2023-02-15 4 xslF345X03/form4-02152023_040213.xml 0001415889-23-002604 4879
2023-02-15 4 xslF345X03/form4-02152023_040208.xml 0001415889-23-002603 4894
2023-02-15 4 xslF345X03/form4-02152023_040201.xml 0001415889-23-002602 4844
2023-02-09 4 xslF345X03/form4-02092023_040202.xml 0001415889-23-002218 4841
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015840 005-89319 23603006 34 12939
2023-02-03 SC 13G/A Editas_Medicine_Inc.txt 0000093751-23-000191 005-89319 23585905 34 10304
2023-01-26 SC 13G/A us28106w1036_012623.txt 0001306550-23-004464 005-89319 23554708 34 13382
2023-01-20 SC 13G/A us28106w1036_012023.txt 0001306550-23-001138 005-89319 23540665 34 13358
2023-01-12 4 xslF345X03/form4-01122023_040101.xml 0001415889-23-000875 5358
2023-01-09 8-K 8-K 5.02 0001558370-23-000130 001-37687 23516762 34 236159 1 1
2022-12-06 4 xslF345X03/form4-12062022_041206.xml 0001415889-22-012132 4892
2022-12-06 4 xslF345X03/form4-12062022_041201.xml 0001415889-22-012131 4853
2022-12-06 8-K 8-K 8.01,9.01 0001558370-22-018383 001-37687 221446663 34 276429 1 1
2022-11-17 8-K 8-K 8.01,9.01 0001558370-22-018016 001-37687 221396841 34 189081 1 1
2022-11-09 4 xslF345X03/form4-11092022_041141.xml 0001415889-22-011242 4853
2022-11-02 10-Q 10-Q 0001558370-22-016012 001-37687 221354611 34 5608141 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001558370-22-015898 001-37687 221352229 34 373169 1 1
2022-10-07 SC 13G/A us28106w1036_100622.txt 0000834237-22-010826 005-89319 221300514 34 13375
2022-09-08 4 xslF345X03/form4-09082022_040910.xml 0001415889-22-009449 4894
2022-09-08 4 xslF345X03/form4-09082022_040901.xml 0001415889-22-009448 4856
2022-08-10 4 xslF345X03/form4-08102022_040801.xml 0001415889-22-008463 5322
2022-08-03 10-Q 10-Q 0001558370-22-011904 001-37687 221133112 34 5690073 1 1
2022-08-03 8-K 8-K 2.02,9.01 0001558370-22-011740 001-37687 221130842 34 299811 1 1
2022-07-20 4 xslF345X03/form4-07202022_010742.xml 0001415889-22-007838 7259
2022-07-20 3 xslF345X02/form3-07202022_010729.xml 0001415889-22-007837 11292
2022-07-11 SC 13G/A EDITAS_MEDICINE_INC.txt 0000093751-22-000569 005-89319 221076510 34 10260
2022-06-16 4 xslF345X03/form4-06162022_040601.xml 0001415889-22-006631 4911
2022-06-13 4 xslF345X03/form4-06132022_040635.xml 0001415889-22-006494 5202
2022-06-13 4 xslF345X03/form4-06132022_040621.xml 0001415889-22-006492 5141
2022-06-13 4 xslF345X03/form4-06132022_040629.xml 0001415889-22-006493 5172
2022-06-13 4 xslF345X03/form4-06132022_040616.xml 0001415889-22-006491 5134
2022-06-13 4 xslF345X03/form4-06132022_040611.xml 0001415889-22-006490 5179
2022-06-13 4 xslF345X03/form4-06132022_040601.xml 0001415889-22-006488 5178
2022-06-13 4 xslF345X03/form4-06132022_040606.xml 0001415889-22-006489 5171
2022-06-13 8-K 8-K 5.07 0001558370-22-009970 001-37687 221011779 34 175943 1 1
2022-06-06 4 xslF345X03/form4-06062022_010614.xml 0001415889-22-006162 4882
2022-06-06 4 xslF345X03/form4-06062022_010617.xml 0001415889-22-006161 4920
2022-06-06 4 xslF345X03/form4-06062022_010612.xml 0001415889-22-006159 7225
2022-06-06 3 xslF345X02/form3-06062022_010613.xml 0001415889-22-006158 10625
2022-05-11 4 xslF345X03/form4-05112022_040501.xml 0001415889-22-004837 5318
2022-05-04 10-Q 10-Q 0001558370-22-007066 001-37687 22892046 34 5017251 1 1
2022-05-04 8-K 8-K 2.02,9.01 0001558370-22-006937 001-37687 22889772 34 283324 1 1
2022-04-26 DEFA14A DEFA14A 0001104659-22-050348 001-37687 22854576 34 645970
2022-04-26 DEF 14A DEF 14A 0001104659-22-050341 001-37687 22854513 34 3107553
2022-04-18 4 xslF345X03/form4-04182022_040401.xml 0001415889-22-004098 5314
2022-04-14 8-K 8-K 5.02 0001558370-22-005418 001-37687 22826014 34 156216 1 1
2022-04-04 4 xslF345X03/form4-04042022_040401.xml 0001415889-22-003709 6759
2022-03-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-031862 005-89319 22724046 34 12932
2022-03-07 4 xslF345X03/form4-03072022_040308.xml 0001415889-22-002656 4851
2022-03-07 4 xslF345X03/form4-03072022_040301.xml 0001415889-22-002655 4889
2022-02-24 S-8 S-8 0001558370-22-001958 333-262977 22671883 33 168413
2022-02-24 10-K 10-K 0001558370-22-001950 001-37687 22671784 34 10128405 1 1
2022-02-24 8-K 8-K 2.02,9.01 0001558370-22-001821 001-37687 22666424 34 297947 1 1
2022-02-14 SC 13G/A SC13G/A 0001140361-22-005028 005-89319 22624449 34 64990
2022-02-11 4 xslF345X03/form4-02112022_010246.xml 0001415889-22-001225 7206
2022-02-11 4 xslF345X03/form4-02112022_010249.xml 0001415889-22-001224 7241
2022-02-11 4 xslF345X03/form4-02112022_010242.xml 0001415889-22-001223 7235
2022-02-10 4 xslF345X03/form4-02102022_010215.xml 0001415889-22-001195 5319
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-017029 005-89319 22607031 34 12934
2022-02-09 SC 13G/A SC 13G/A 0001104659-22-016148 005-89319 22605892 34 40369
2022-02-07 8-K 8-K 5.02 0001558370-22-000862 001-37687 22597628 34 147441 1 1
2022-02-04 SC 13G/A AMENDMENT NO. 3 0001214659-22-001842 005-89319 22590796 34 67087
2022-02-03 SC 13G/A us28106w1036_020322.txt 0000834237-22-006425 005-89319 22589201 34 13343
2022-01-13 4 FORM 4 - 0001179110-22-000470 4821
2022-01-04 4 FORM 4 - 0001179110-22-000112 4847
2021-12-23 4 FORM 4 - 0001179110-21-011227 4785
2021-12-23 4 FORM 4 - 0001179110-21-011226 4799
2021-12-23 4 FORM 4 - 0001179110-21-011225 4828
2021-12-23 4 FORM 4 - 0001179110-21-011224 4814
2021-12-23 4 FORM 4 - 0001179110-21-011223 4674
2021-11-15 4 FORM 4 - 0001179110-21-010113 4808
2021-11-10 4 FORM 4 - 0001179110-21-010059 4789
2021-11-09 10-Q 10-Q 0001558370-21-015161 001-37687 211389883 34 8355050 1 1
2021-11-08 8-K 8-K 2.02,9.01 0001558370-21-014923 001-37687 211386514 34 262197 1 1
2021-10-28 4 FORM 4 - 0001179110-21-009688 5246
2021-10-28 3 FORM 3 - 0001179110-21-009687 8000
2021-10-28 8-K 8-K 5.02 0001558370-21-013688 001-37687 211355361 34 152605 1 1
2021-10-20 4 FORM 4 - 0001179110-21-009557 4849
2021-10-15 CT ORDER filename1.pdf 20211015,20211015 9999999997-21-005256 001-37687 211324703 34 162099
2021-10-04 4 FORM 4 - 0001179110-21-009149 4674
2021-09-29 8-K 8-K 7.01,8.01,9.01 0001558370-21-012862 001-37687 211289561 34 194706 1 1
2021-09-08 4 FORM 4 - 0001179110-21-008671 5219
2021-09-08 3 FORM 3 - 0001179110-21-008670 8103
2021-09-08 8-K 8-K 5.02 0001558370-21-012312 001-37687 211242359 34 153016 1 1
2021-08-10 4 FORM 4 - 0001179110-21-008086 8341
2021-08-05 10-Q 10-Q 0001558370-21-010390 001-37687 211146342 34 5722950 1 1
2021-08-04 8-K 8-K 2.02,9.01 0001558370-21-010084 001-37687 211142329 34 264767 1 1
2021-07-30 3 FORM 3 - 0001179110-21-007765 13908
2021-07-13 CT ORDER filename1.pdf 20210713,20210713 9999999997-21-004079 001-37687 211086821 34 121342
2021-06-30 4 FORM 4 - 0001179110-21-007175 8344
2021-06-16 4 FORM 4 - 0001179110-21-006780 5263
2021-06-16 4 FORM 4 - 0001179110-21-006778 7125
2021-06-16 3 FORM 3 - 0001179110-21-006777 7986
2021-06-08 8-K 8-K 5.07 0001558370-21-008121 001-37687 211002335 34 169146 1 1
2021-06-07 4 FORM 4 - 0001179110-21-006458 9470
2021-06-07 4 FORM 4 - 0001179110-21-006454 9441
2021-06-07 4 FORM 4 - 0001179110-21-006452 9494
2021-06-07 4 FORM 4 - 0001179110-21-006451 9478
2021-06-07 4 FORM 4 - 0001179110-21-006450 5114
2021-05-21 DEFA14A DEFA14A 0001104659-21-070138 001-37687 21946529 34 2505897
2021-05-14 8-K FORM 8-K 1.01,9.01 0001104659-21-066941 001-37687 21925641 34 482058 1 1
2021-05-14 424B5 424B5 0001104659-21-066936 333-253715 21925608 33 542308
2021-05-06 10-Q 10-Q 0001558370-21-006073 001-37687 21895823 34 5025917 1 1
2021-05-05 8-K 8-K 2.02,9.01 0001558370-21-005794 001-37687 21891139 34 270037 1 1
2021-04-20 DEFA14A DEFA14A 0001104659-21-052536 001-37687 21838042 34 708690
2021-04-20 DEF 14A DEF 14A 0001104659-21-052527 001-37687 21838009 34 2764782
2021-03-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000916 275412
2021-03-05 4 FORM 4 - 0001179110-21-002936 9149
2021-03-04 4 FORM 4 - 0001179110-21-002870 11369
2021-03-04 4 FORM 4 - 0001179110-21-002869 11642
2021-03-01 S-8 S-8 0001558370-21-002178 333-253716 21698367 33 146535
2021-03-01 S-3ASR S-3ASR 0001104659-21-030025 333-253715 21698352 33 1498817
2021-02-26 10-K 10-K 0001558370-21-001915 001-37687 21683785 34 12065769 1 1
2021-02-25 8-K 8-K 2.02,9.01 0001558370-21-001723 001-37687 21676456 34 292458 1 1
2021-02-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000810 276766
2021-02-19 8-K/A 8-K/A 5.02 0001558370-21-001289 001-37687 21655771 34 151155 1 1
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-024181 005-89319 21639379 34 43062
2021-02-11 SC 13G/A SC 13G/A 0001140361-21-004348 005-89319 21620019 34 67637
2021-02-10 4 FORM 4 - 0001179110-21-001512 5213
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017967 005-89319 21610607 34 13774
2021-02-08 8-K FORM 8-K 5.02,9.01 0001104659-21-013334 001-37687 21598611 34 223895 1 1
2021-02-05 SC 13G/A AMENDMENT NO. 2 0001214659-21-001369 005-89319 21593351 34 66725
2021-01-29 SC 13G/A us28106w1036_012921.txt 0000834237-21-003812 005-89319 21568691 34 13324
2021-01-21 8-K FORM 8-K 1.01,8.01,9.01 0001104659-21-006336 001-37687 21542601 34 471903 1 1
2021-01-21 424B5 424B5 0001047469-21-000159 333-223596 21542567 33 666310
2021-01-19 8-K FORM 8-K 2.02,8.01,9.01 0001104659-21-005360 001-37687 21535968 34 215440 1 1
2021-01-19 424B5 424B5 0001047469-21-000132 333-223596 21535938 33 662596
2021-01-13 4 FORM 4 - 0001179110-21-000574 4821
2021-01-11 8-K FORM 8-K 5.02,8.01,9.01 0001104659-21-002967 001-37687 21520869 34 227939 1 1
2021-01-11 424B7 424B7 0001104659-21-002964 333-223596 21520855 33 34845
2020-12-18 4 FORM 4 - 0001179110-20-012101 5224
2020-12-18 3 FORM 3 - 0001179110-20-012100 7961
2020-12-18 8-K 8-K 5.02 0001558370-20-014467 001-37687 201400889 34 152284 1 1
2020-12-17 4 FORM 4 - 0001179110-20-012070 11996
2020-12-11 4 FORM 4 - 0001179110-20-011830 8273
2020-12-08 4 FORM 4 - 0001179110-20-011752 8734
2020-11-10 4 FORM 4 - 0001179110-20-010969 7115
2020-11-10 3 FORM 3 - 0001179110-20-010967 8060
2020-11-10 4 FORM 4 - 0001179110-20-010963 4761
2020-11-06 10-Q 10-Q 0001558370-20-013022 001-37687 201292471 34 7234267 1 1
2020-11-05 8-K 8-K 2.02,9.01 0001558370-20-012865 001-37687 201290680 34 256226 1 1
2020-10-16 4 FORM 4 - 0001179110-20-010507 4984
2020-10-09 SC 13G/A SC 13G/A 0001104659-20-113794 005-89319 201232780 34 46429
2020-08-21 4 FORM 4 - 0001179110-20-009219 5213
2020-08-19 4 FORM 4 - 0001179110-20-009170 8728
2020-08-10 4 FORM 4 - 0001179110-20-008833 10523
2020-08-07 10-Q 10-Q 0001558370-20-009821 001-37687 201083788 34 6103809 1 1
2020-08-06 8-K 8-K 1.01,1.02,2.02,9.01 0001558370-20-009648 001-37687 201081680 34 263911 1 1
2020-07-17 4 FORM 4 - 0001179110-20-008367 4525
2020-06-25 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-076658 001-37687 20987151 34 478484 1 1
2020-06-25 424B5 424B5 0001047469-20-003852 333-239389 20987149 33 486021
2020-06-23 S-3ASR S-3ASR 0001047469-20-003806 333-239389 20982047 33 566452
2020-06-15 8-K 8-K 5.07 0001558370-20-007536 001-37687 20963347 34 165797 1 1
2020-06-12 4 FORM 4 - 0001179110-20-007280 5175
2020-06-12 4 FORM 4 - 0001179110-20-007277 5116
2020-06-12 4 FORM 4 - 0001179110-20-007273 5109
2020-06-12 4 FORM 4 - 0001179110-20-007265 5077
2020-06-12 4 FORM 4 - 0001179110-20-007263 5063
2020-05-15 424B5 424B5 0001047469-20-003096 333-223596 20885577 33 359665
2020-05-15 8-K 8-K 1.01,9.01 0001558370-20-006724 001-37687 20884960 34 644847 1 1
2020-05-08 4 FORM 4 - 0001179110-20-005605 4784
2020-05-08 10-Q 10-Q 0001558370-20-005883 001-37687 20858820 34 5209535 1 1
2020-05-07 8-K 8-K 2.02,9.01 0001558370-20-005548 001-37687 20854592 34 271636 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (323 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 154.34M 2026-11-06 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
dei EntityPublicFloat Entity Public Float USD 191.38M 2025-06-30 2025 FY 10-K 2026-03-09 0001650664-26-000017
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.17M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001650664-26-000037
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 999,023 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001650664-26-000037
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 23.11 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001650664-26-000037
ffd NetFeeAmt NetFeeAmt USD 397.52 2026-09-09 S-8 2026-09-09 0001650664-26-000090
ffd TtlFeeAmt TtlFeeAmt USD 397.52 2026-09-09 S-8 2026-09-09 0001650664-26-000090
ffd TtlOfferingAmt TtlOfferingAmt USD 2.88M 2026-09-09 S-8 2026-09-09 0001650664-26-000090
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-09 S-8 2026-09-09 0001650664-26-000090
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-28 S-3 2026-08-31 0001104659-26-103906
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4.92M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001650664-24-000121
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 18.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 88,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AccruedRentCurrent Accrued Rent, Current USD 18,000 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap AccruedRentNoncurrent Accrued Rent, Noncurrent USD 380,000 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 27.08M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -96,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.78B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 47,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.57M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 62,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 445,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 69.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap Assets Assets USD 219.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AssetsCurrent Assets, Current USD 201.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 192.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 96,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 190.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 329.14M 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2017-06-30 2017 Q2 10-Q 2017-08-09 0001558370-17-006422
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 76,000 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 329.21M 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 174.00M 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 190.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap BusinessExitCosts1 Business Exit Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 3.78M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-05 0001558370-23-008308
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 32.42M 2018-12-31 2019 Q1 10-Q 2019-05-08 0001558370-19-004444
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 93.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 146.65M 2025-12-31 2026 Q2 10-Q 2026-08-05 0001650664-26-000083
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -98.78M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001558370-17-008429
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 95.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -53.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 23,076 2016-02-29 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 55.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 24.01M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 390.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 153.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 97.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap CommonStockValue Common Stock, Value, Issued USD 15,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -66.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 13.73M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 36.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 32.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 4.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 15.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 199.91M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001558370-16-009820
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 803,000 2019-03-31 2020 Q2 10-Q 2020-08-07 0001558370-20-009821
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 20,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2025-06-30 2025 Q2 10-Q 2025-08-12 0001650664-25-000125
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions security 0 2024-03-31 2024 Q1 10-Q 2024-05-08 0001650664-24-000037
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 26.60M 2019-12-31 2019 FY 10-K 2020-02-26 0001558370-20-001476
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 2,000 2024-09-30 2024 Q3 10-Q 2024-11-04 0001650664-24-000121
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 0 2025-03-31 2025 Q1 10-Q 2025-05-12 0001650664-25-000073
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-13 0001558370-16-005983
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 4.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredOfferingCosts Deferred Offering Costs USD -283,000 2015-12-31 2016 Q2 10-Q 2016-08-10 0001558370-16-007838
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 13.24M 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 94.72M 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction USD 9.10M 2018-12-31 2019 FY 10-K 2020-02-26 0001558370-20-001476
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 11.71M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 48.08M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 436.44M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 4.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 231.98M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 75.50M 2020-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 15.42M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 35.95M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 84.70M 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.38M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 3.48M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 432.20M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DeferredTaxLiabilitiesDeferredExpense Deferred Tax Liabilities, Deferred Expense USD 335,000 2021-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001950
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 2 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap Depreciation Depreciation USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.67 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001558370-21-010390
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.203 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.002 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.026 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 9.80M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap EquitySecuritiesFvNiRealizedGain Equity Securities, FV-NI, Realized Gain USD 16.37M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-22 0001558370-23-001764
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 13.11M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-09 0001558370-21-015161
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 87,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 87,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-10 0001558370-16-007838
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 376,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-10 0001558370-16-007838
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 289,000 2015-12-31 2016 Q2 10-Q 2016-08-10 0001558370-16-007838
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 32.42M 2018-12-31 2019 FY 10-K 2020-02-26 0001558370-20-001476
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -111,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 35.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 3.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.74 2019-10-01 2019-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 32.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -33.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 178,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 4.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -7.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -14.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -8.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 81.71M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -4.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -258,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 1.27M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 1.62M 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001558370-17-008429
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 465,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 13,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap InvestmentIncomeNet Investment Income, Net USD 4.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.80M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap LeaseCost Lease, Cost USD 5.10M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 20.46M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0001650664-24-000008
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 7.39M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6.00M 2023-12-31 2023 FY 10-K 2024-02-28 0001650664-24-000008
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.00M 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 6.00M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 7.08M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.09M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.36M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap Liabilities Liabilities USD 134.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 219.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LiabilitiesCurrent Liabilities, Current USD 71.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LongTermDebt Long-term Debt USD 57.43M 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 49.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap LossOnContractTermination Loss on Contract Termination USD 4.80M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap MarketableSecurities Marketable Securities USD 460.81M 2019-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 97.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 117.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 97.09M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001558370-17-004338
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -96.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -656,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001558370-17-004338
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -73.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 69.79M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001558370-17-004338
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -66.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -220.43M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0001558370-23-001764
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -220.43M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-22 0001558370-23-001764
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NotesIssued1 Notes Issued USD 12.50M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap NotesPayable Notes Payable USD 7.50M 2017-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 35.49M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001558370-18-004024
us-gaap OperatingExpenses Operating Expenses USD 92.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -67.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingLeaseCost Operating Lease, Cost USD 14.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.10M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 7.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 12.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 29.06M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.96M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 4.36M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 4.26M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.16M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.05M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 8.27M 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.092 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 147.80M 2018-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 376,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 2.87M 2018-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.98M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -6,000 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-02 0001558370-23-012936
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.68M 2019-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -97,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap OtherRestructuringCosts Other Restructuring Costs USD -1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 80,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.76M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 300,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-22 0001558370-23-001764
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 116.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 198,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2022-09-30 2022 Q3 10-Q 2022-11-02 0001558370-22-016012
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.92M 2018-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 1.50M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.20B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 116.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 57.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 141.71M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 6,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 20.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 187,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -89.33M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-02 0001558370-23-012936
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 29.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 7.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001558370-17-004338
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 857,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 2.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 600,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001558370-20-001476
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 58.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 27.50M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-22 0001558370-23-001764
us-gaap RestrictedCash Restricted Cash USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.67M 2025-12-31 2026 Q2 10-Q 2026-08-05 0001650664-26-000083
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 3.90M 2021-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001950
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 2.70M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 320,000 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated position 180 2024-12-11 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.65 2024-12-11 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RestructuringCharges Restructuring Charges USD 79.17M 2024-12-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001650664-25-000125
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 1.80M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 30.54M 2025-03-31 2025 Q1 10-Q 2025-05-12 0001650664-25-000073
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD -1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.70B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 25.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 31.94M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap Revenues Revenues USD 2.07M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001558370-19-004444
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 793,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap SeveranceCosts1 Severance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 51,182 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 21.4 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 445,126 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 21.94 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 586,892 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 24.2 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 77,052 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 26.47 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 13.24M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.39M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 21.5 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 587,594 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 546,799 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 28.15 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.50M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 14.90M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.14M 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 24.69 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 61.94M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001558370-18-004024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.30M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001558370-18-004024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 22.61 2018-03-31 2018 Q1 10-Q 2018-05-04 0001558370-18-004024
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 11.46 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 16.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 24.3 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 37.04M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001558370-18-001721
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 84.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.385 2016-01-15 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap StockIssued1 Stock Issued USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 24.93M 2016-02-01 2016-02-29 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 6.90M 2020-06-01 2020-06-30 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 502,234 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001558370-19-010798
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 199.96M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 228,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 27.50M 2021-01-01 2021-03-31 2022 Q3 10-Q 2022-11-02 0001558370-22-016012
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 116.88M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 1.94M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001650664-24-000121
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 590,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-05 0001650664-25-000022
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 151,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap StraightLineRentAdjustments Straight Line Rent Adjustments USD 310,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 47,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 47,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001558370-19-001364
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 17.10M 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 43.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001650664-26-000017
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 289,000 2015-12-31 2016 FY 10-K 2017-03-03 0001558370-17-001340
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 123.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 58.61M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001558370-21-001915
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 123.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001650664-26-000103

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →